Review on Virosomes: As a Drug Delivery Carriers

Author:

Dipali Katare 1,Bilal Sufi 1,Jayesh D. Nil 1,Ashwini Ashtankar 1

Affiliation:

1. New Montfort Institute of Pharmacy, Ashti, Wardha, Maharashtra, India

Abstract

Since the last era, some revolutionary advances in drug delivery technologies have been observed in the realization of targeted drug delivery or targeted drug action at the site. The prospects for the use of biological molecules nanoparticles such as virosomes as drugs are motivating research and development areas that show the targeted fusion effects with the targeted fusion effects by target cells. Virosomes are biocompatible, biodegradable, non-toxic and non-autoimmunogeneous viral species and are new carriers and drug delivery systems for vaccines and cell delivery of active macromolecules. Virosomes are biomimetic nanoparticle drug delivery systems that contain active macromolecules in a virus coat made of lipoid membranes. The administration of virosomes takes place through various methods such as the intramuscular (IM), intravenous (IV), intravascular, subcutaneous (SC), oral and inhalation routes. The research paper focuses on the structure, components, types and formulations of virosomes, the mechanism of action and applications of viral genes, and available commercial formulations.

Publisher

Naksh Solutions

Subject

General Medicine

Reference24 articles.

1. Kalra, N., et al. 2013. Virosomes : As a Drug Delivery Carrier. American Journal of Advanced Drug Delivery, 1(1):29–35.

2. Almeida JD, Brand CM, Edwards DC, Heath TD. Formation of virosomes from influenza subunits and liposomes. Lancet. 1975;2:899–901.

3. Bhattacharya Sanjib, Muzumder Bhaskar. Virosomes A Novel Strategy for Drug Delivery and Targeting. Biopharm International, 2011; volume 2011 Supplement (issue1).

4. Idris N, Chilkawar R, Nanjwade B, Srichana T, Shafioul A. Nanotechnology Based Virosomal Drug Delivery Systems. Journal of Nanotechnology and Materials Science 2014; 1(1):27- 35.

5. Morein, B., et al. 1978. Effective subunit vaccines against an enveloped animal virus. Nature, 276(5689):715–718.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3